Therapeutically active compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4442300
SERIAL NO

06279467

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

New bronchospasmolytically active compounds exhibiting long duration of action and reduced undesired side effects, of the structural formula ##STR1## and therapeutically acceptable salts thereof, in which formula R, R.sup.1 and R.sup.2 are as follows: R is selected from the group consisting of --C(CH.sub.3).sub.3, ##STR2## R.sup.1 is selected from the group consisting of H and R.sup.2 ; R.sup.2 is selected from the group consisting of ##STR3## in which formulas R.sup.3 is selected from the group consisting of (a) H; ##STR4## wherein R.sup.5 is a straight or branched alkyl group containing 1-4 carbon atoms; and ##STR5## and wherein R.sup.4 is selected from the group consisting of (a) H (b) an alkyl group containing 1-3 carbon atoms, process for the preparation thereof, chemical intermediates at their preparation, pharmaceutical compositions containing them and their medicinal use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AKTIEBOLAG DRACO A COMPANY OF SWEDENLUND

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Olsson, O A Torsten Lund, SE 3 23
Svensson, Leif ANG Lund, SE 1 9
Wetterlin, Kjell I L Sandby, SE 13 980

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation